1 Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol. 2005 Jun;6(6):401–10.
2 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008 Aug;359(9):938–49.
3 Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007 Sep; 110(6):
1723–9.
4 Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):381S–453S.
5 Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000 Mar;160(6):
809–15.
6 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Trends in the incidence of deep
vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998 Mar;
158(6):585–93.
7 Sakon M, Kakkar AK, Ikeda M, Sekimoto M, Nakamori S, Yano M, et al. Current status of pulmonary embolism
in general surgery in Japan. Surg Today. 2004;34(10):805–10.
8 Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin
in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001 Jul;88(7):913–30.
9 Geahchan N, Basile M, Tohmeh M; DIONYS registry. Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry.
Springerplus. 2016 Sep;5(1):1541.
10 Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, et al.; American Society of Clinical Oncology.
Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical
oncology clinical practice guideline update 2014. J Clin Oncol. 2015 Feb;33(6):654–6.
11 Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic
Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical
Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e227S–e277S.
12 Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al.; ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive
advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled
trial. Lancet. 2010 Aug;376(9742):687–97.
13 Chang SC, Liu KH, Hung CY, Tsai CY, Hsu JT, Yeh TS, et al. Adjuvant Chemotherapy Improves Survival in Stage
III Gastric Cancer after D2 Surgery. J Cancer. 2018 Jan;9(1):81–91.
14 Tanizawa Y, Bando E, Kawamura T, Tokunaga M, Makuuchi R, Iida K, et al. Prevalence of deep venous thrombosis detected by ultrasonography before surgery in patients with gastric cancer: a retrospective study of
1140 consecutive patients. Gastric Cancer. 2017 Sep;20(5):878–86.
15 Lee KW, Bang SM, Kim S, Lee HJ, Shin DY, Koh Y, et al. The incidence, risk factors and prognostic implications
of venous thromboembolism in patients with gastric cancer. J Thromb Haemost. 2010 Mar;8(3):540–7.
16 Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification
of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187–96.
17 Niimi R, Hasegawa M, Sudo A, Shi D, Yamada T, Uchida A. Evaluation of soluble fibrin and D-dimer in the diagnosis of postoperative deep vein thrombosis. Biomarkers. 2010 Mar;15(2):149–57.
18 Jung YJ, Seo HS, Park CH, Jeon HM, Kim JI, Yim HW, et al. Venous Thromboembolism Incidence and Prophylaxis
Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized
Clinical Trial. JAMA Surg. 2018 Oct;153(10):939–46.
19 Osaki T, Saito H, Fukumoto Y, Kono Y, Murakami Y, Shishido Y, et al. Risk and incidence of perioperative deep
vein thrombosis in patients undergoing gastric cancer surgery. Surg Today. 2018 May;48(5):525–33.
20 Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based
Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e152S–84S.
21 Felder S, Rasmussen MS, King R, et al. Prolonged thromboprophylaxis with low molecular weight heparin for
abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004318.
22 Riess H, Habbel P, Jühling A, Sinn M, Pelzer U. Primary prevention and treatment of venous thromboembolic
events in patients with gastrointestinal cancers - Review. World J Gastrointest Oncol. 2016 Mar;8(3):258–70.
23 Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012
Feb;141(2 Suppl):7S–47S.
24 Li M, Guo Q, Hu W. Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery:
A systematic review and meta-analysis. Thromb Res. 2019 Jan;173:48–56.
25 Nielsen AW, Helm MC, Kindel T, Higgins R, Lak K, Helmen ZM, et al. Perioperative bleeding and blood transfusion are major risk factors for venous thromboembolism following bariatric surgery. Surg Endosc. 2018
May;32(5):2488–95.
26 Kimura Y, Oki E, Ando K, Saeki H, Kusumoto T, Maehara Y. Incidence of Venous Thromboembolism Following
Laparoscopic Surgery for Gastrointestinal Cancer: A Single-Center, Prospective Cohort Study. World J Surg.
2016 Feb;40(2):309–14.
...
論文の公開元へ
